Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin
Authors:
- Joan C EgrieJEJoan C Egrie
- Erik DwyerEDErik Dwyer
- Jeffrey K BrowneJBJeffrey K Browne
- Anna HitzAHAnna Hitz
- Michele A LykosMLMichele A Lykos
- 1 April 2003
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 31 (4) , 290-299
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The Erythropoietin Receptor: Structure, Activation and Intracellular Signal TransductionTrends in Endocrinology & Metabolism, 1999
- Epoetin AlfaDrugs, 1995
- S7.7 The role of carbohydrate on the biological activity of erythropoietinGlycoconjugate Journal, 1993
- The role of carbohydrate in recombinant human erythropoietinEuropean Journal of Biochemistry, 1990
- Expression cloning of the murine erythropoietin receptorCell, 1989
- Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment-mass spectrometryBiochemistry, 1988
- Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietinsBiochemistry, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970